Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Downregulated adhesion-associated microRNAs as prognostic predictors in childhood osteosarcoma (2018)

  • Authors:
  • USP affiliated authors: ENGEL, EDGARD EDUARD - FMRP ; SCRIDELI, CARLOS ALBERTO - FMRP ; ANNICHINI, MARIA SOL BRASSESCO - FFCLRP ; TONE, LUIZ GONZAGA - FMRP
  • USP Schools: FMRP; FMRP; FFCLRP; FMRP
  • DOI: 10.1007/s12253-017-0316-1
  • Subjects: METÁSTASE NEOPLÁSICA; ADERÊNCIA CELULAR; MICRORNAS; OSTEOSSARCOMA
  • Keywords: microRNAs; Adhesion; Osteosarcoma; Metastasis
  • Agências de fomento:
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s12253-017-0316-1 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      DELSIN, L. E. A.; ROBERTO, G. M.; FEDATTO, Paola Fernanda; et al. Downregulated adhesion-associated microRNAs as prognostic predictors in childhood osteosarcoma. Pathology & Oncology Research, Dordrecht, 2018. Disponível em: < http://dx.doi.org/10.1007/s12253-017-0316-1 > DOI: 10.1007/s12253-017-0316-1.
    • APA

      Delsin, L. E. A., Roberto, G. M., Fedatto, P. F., Engel, E. E., Scrideli, C. A., Tone, L. G., & Brassesco, M. S. (2018). Downregulated adhesion-associated microRNAs as prognostic predictors in childhood osteosarcoma. Pathology & Oncology Research. doi:10.1007/s12253-017-0316-1
    • NLM

      Delsin LEA, Roberto GM, Fedatto PF, Engel EE, Scrideli CA, Tone LG, Brassesco MS. Downregulated adhesion-associated microRNAs as prognostic predictors in childhood osteosarcoma [Internet]. Pathology & Oncology Research. 2018 ;Available from: http://dx.doi.org/10.1007/s12253-017-0316-1
    • Vancouver

      Delsin LEA, Roberto GM, Fedatto PF, Engel EE, Scrideli CA, Tone LG, Brassesco MS. Downregulated adhesion-associated microRNAs as prognostic predictors in childhood osteosarcoma [Internet]. Pathology & Oncology Research. 2018 ;Available from: http://dx.doi.org/10.1007/s12253-017-0316-1

    Referências citadas na obra
    Gee HE, Ivan C, Calin GA, Ivan M (2014) HypoxamiRs and cancer: from biology to targeted therapy. Antioxid Redox Signal 21(8):1220–1238. https://doi.org/10.1089/ars.2013.5639
    Olivieri F, Rippo MR, Procopio AD, Fazioli F (2013) Circulating inflamma-miRs in aging and age-related diseases. Front Genet 4:121. https://doi.org/10.3389/fgene.2013.00121
    Schickel R, Boyerinas B, Park SM, Peter ME (2008) MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 27(45):5959–5974. https://doi.org/10.1038/onc.2008.274
    Tutar L, Tutar E, Özgür A, Tutar Y (2015) Therapeutic Targeting of microRNAs in Cancer: Future Perspectives. Drug Dev Res 76(7):382–388. https://doi.org/10.1002/ddr.21273
    Hurst DR, Edmonds MD, Welch DR (2009) Metastamir: the field of metastasis-regulatory microRNA is spreading. Cancer Res 69(19):7495–7498. https://doi.org/10.1158/0008-5472.CAN-09-2111
    Sengupta S, den Boon JA, Chen IH, Newton MA, Stanhope SA, Cheng YJ, Chen CJ, Hildesheim A, Sugden B, Ahlquist P (2008) MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc Natl Acad Sci U S A 105(15):5874–5878. https://doi.org/10.1073/pnas.0801130105
    Tavazoie SF, Alarcón C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL, Massagué J (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451(7175):147–152. https://doi.org/10.1038/nature06487
    Gregory PA, Bracken CP, Bert AG, Goodall GJ (2008) MicroRNAs as regulators of epithelial-mesenchymal transition. Cell Cycle 7(20):3112–3118. https://doi.org/10.4161/cc.7.20.6851
    Ma L, Teruya-Feldstein J, Weinberg RA (2007) Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449(7163):682–688. https://doi.org/10.1038/nature06174
    Wang Y, Li Z, Zhao X, Zuo X, Peng Z (2016) miR-10b promotes invasion by targeting HOXD10 in colorectal cancer. Oncol Lett 12(1):488–494. https://doi.org/10.3892/ol.2016.4628
    Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo YY (2008) MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 18(3):350–359. https://doi.org/10.1038/cr.2008.24
    Hurst DR, Edmonds MD, Scott GK, Benz CC, Vaidya KS, Welch DR (2009) Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res 69(4):1279–1283. https://doi.org/10.1158/0008-5472.CAN-08-3559
    Massagué J, Obenauf AC (2016) Metastatic colonization by circulating tumour cells. Nature 529(7586):298–306. https://doi.org/10.1038/nature17038
    Talmadge JE, Fidler IJ (2010) AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res 70(14):5649–5669. https://doi.org/10.1158/0008-5472.CAN-10-1040
    Nicoloso MS, Spizzo R, Shimizu M, Rossi S, Calin GA (2009) MicroRNAs--the micro steering wheel of tumour metastases. Nat Rev Cancer 9(4):293–302. https://doi.org/10.1038/nrc2619
    Le XF, Merchant O, Bast RC, Calin GA (2010) The Roles of MicroRNAs in the Cancer Invasion-Metastasis Cascade. Cancer Microenviron 3(1):137–147. https://doi.org/10.1007/s12307-010-0037-4
    le Sage C, Nagel R, Egan DA, Schrier M, Mesman E, Mangiola A, Anile C, Maira G, Mercatelli N, Ciafrè SA, Farace MG, Agami R (2007) Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J 26(15):3699–3708. https://doi.org/10.1038/sj.emboj.7601790
    Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, Huang Y, Hu X, Su F, Lieberman J, Song E (2007) let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131(6):1109–1123. https://doi.org/10.1016/j.cell.2007.10.054
    Gorlick R, Khanna C (2010) Osteosarcoma. J Bone Miner Res 25(4):683–691. https://doi.org/10.1002/jbmr.77
    Kushlinskii NE, Fridman MV, Braga EA (2016) Molecular Mechanisms and microRNAs in Osteosarcoma Pathogenesis. Biochemistry (Mosc) 81(4):315–328. https://doi.org/10.1134/S0006297916040027
    Ram Kumar RM, Boro A, Fuchs B (2016) Involvement and Clinical Aspects of MicroRNA in Osteosarcoma. Int J Mol Sci 17(6). https://doi.org/10.3390/ijms17060877
    Geng S, Zhang X, Chen J, Liu X, Zhang H, Xu X, Ma Y, Li B, Zhang Y, Bi Z, Yang C (2014) The tumor suppressor role of miR-124 in osteosarcoma. PLoS One 9(6):e91566. https://doi.org/10.1371/journal.pone.0091566
    Zhao H, Li M, Li L, Yang X, Lan G, Zhang Y (2013) MiR-133b is down-regulated in human osteosarcoma and inhibits osteosarcoma cells proliferation, migration and invasion, and promotes apoptosis. PLoS One 8(12):e83571. https://doi.org/10.1371/journal.pone.0083571
    Huang J, Gao K, Lin J, Wang Q (2014) MicroRNA-100 inhibits osteosarcoma cell proliferation by targeting Cyr61. Tumour Biol 35(2):1095–1100. https://doi.org/10.1007/s13277-013-1146-8
    Wu P, Liang J, Yu F, Zhou Z, Tang J, Li K (2016) miR-145 promotes osteosarcoma growth by reducing expression of the transcription factor friend leukemia virus integration 1. Oncotarget. doi: 10.18632/oncotarget.9948
    Li X, Yang H, Tian Q, Liu Y, Weng Y (2014) Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma. Neoplasma 61(4):453–460. https://doi.org/10.4149/neo_2014_056
    Huang G, Nishimoto K, Zhou Z, Hughes D, Kleinerman ES (2012) miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression. Cancer Res 72(4):908–916. https://doi.org/10.1158/0008-5472.CAN-11-1460
    Ma C, Zhan C, Yuan H, Cui Y, Zhang Z (2016) MicroRNA-603 functions as an oncogene by suppressing BRCC2 protein translation in osteosarcoma. Oncol Rep 35(6):3257–3264. https://doi.org/10.3892/or.2016.4718
    Xu SH, Yang YL, Han SM, Wu ZH (2014) MicroRNA-9 expression is a prognostic biomarker in patients with osteosarcoma. World J Surg Oncol 12:195. https://doi.org/10.1186/1477-7819-12-195
    Maire G, Martin JW, Yoshimoto M, Chilton-MacNeill S, Zielenska M, Squire JA (2011) Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma. Cancer Genet 204(3):138–146. https://doi.org/10.1016/j.cancergen.2010.12.012
    Jones KB, Salah Z, Del Mare S, Galasso M, Gaudio E, Nuovo GJ, Lovat F, LeBlanc K, Palatini J, Randall RL, Volinia S, Stein GS, Croce CM, Lian JB, Aqeilan RI (2012) miRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer Res 72(7):1865–1877. https://doi.org/10.1158/0008-5472.CAN-11-2663
    Namløs HM, Meza-Zepeda LA, Barøy T, Østensen IH, Kresse SH, Kuijjer ML, Serra M, Bürger H, Cleton-Jansen AM, Myklebost O (2012) Modulation of the osteosarcoma expression phenotype by microRNAs. PLoS One 7(10):e48086. https://doi.org/10.1371/journal.pone.0048086
    Lulla RR, Costa FF, Bischof JM, Chou PM, de F Bonaldo M, Vanin EF, Soares MB (2011) Identification of Differentially Expressed MicroRNAs in Osteosarcoma. Sarcoma 2011:732690. https://doi.org/10.1155/2011/732690
    Wang W, Zhou X, Wei M (2015) MicroRNA-144 suppresses osteosarcoma growth and metastasis by targeting ROCK1 and ROCK2. Oncotarget 6(12):10297–10308. 10.18632/oncotarget.3305
    Shen L, Wang P, Yang J, Li X (2014) MicroRNA-217 regulates WASF3 expression and suppresses tumor growth and metastasis in osteosarcoma. PLoS One 9(10):e109138. https://doi.org/10.1371/journal.pone.0109138
    Han K, Chen X, Bian N, Ma B, Yang T, Cai C, Fan Q, Zhou Y, Zhao TB (2015) MicroRNA profiling identifies MiR-195 suppresses osteosarcoma cell metastasis by targeting CCND1. Oncotarget 6 (11):8875-8889. doi: 10.18632/oncotarget.3560
    Poos K, Smida J, Nathrath M, Maugg D, Baumhoer D, Korsching E (2013) How microRNA and transcription factor co-regulatory networks affect osteosarcoma cell proliferation. PLoS Comput Biol 9(8):e1003210. https://doi.org/10.1371/journal.pcbi.1003210
    Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods 25(4):402–408. https://doi.org/10.1006/meth.2001.1262
    Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C (2006) Clonogenic assay of cells in vitro. Nat Protoc 1(5):2315–2319. https://doi.org/10.1038/nprot.2006.339
    Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9(7):671–675
    Zhang J, Yan YG, Wang C, Zhang SJ, Yu XH, Wang WJ (2015) MicroRNAs in osteosarcoma. Clin Chim Acta 444:9–17. https://doi.org/10.1016/j.cca.2015.01.025
    Zhang HD, Jiang LH, Sun DW, Li J, Tang JH (2015) MiR-139-5p: promising biomarker for cancer. Tumour Biol 36(3):1355–1365. https://doi.org/10.1007/s13277-015-3199-3
    Chen X, Shi K, Wang Y, Song M, Zhou W, Tu H, Lin Z (2015) Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation. Oncotarget 6 (35):37544-37556. doi: 10.18632/oncotarget.6065
    Liu X, Duan B, Dong Y, He C, Zhou H, Sheng H, Gao H, Zhang X (2014) MicroRNA-139-3p indicates a poor prognosis of colon cancer. Int J Clin Exp Pathol 7(11):8046–8052
    Yonemori M, Seki N, Yoshino H, Matsushita R, Miyamoto K, Nakagawa M, Enokida H (2016) Dual tumor-suppressors miR-139-5p and miR-139-3p targeting matrix metalloprotease 11 in bladder cancer. Cancer Sci 107(9):1233–1242. https://doi.org/10.1111/cas.13002
    Ratert N, Meyer HA, Jung M, Lioudmer P, Mollenkopf HJ, Wagner I, Miller K, Kilic E, Erbersdobler A, Weikert S, Jung K (2013) miRNA profiling identifies candidate mirnas for bladder cancer diagnosis and clinical outcome. J Mol Diagn 15(5):695–705. https://doi.org/10.1016/j.jmoldx.2013.05.008
    Wang Z, Ding Q, Li Y, Liu Q, Wu W, Wu L, Yu H (2016) Reanalysis of microRNA expression profiles identifies novel biomarkers for hepatocellular carcinoma prognosis. Tumour Biol. https://doi.org/10.1007/s13277-016-5369-3
    Haakensen VD, Nygaard V, Greger L, Aure MR, Fromm B, Bukholm IR, Lüders T, Chin SF, Git A, Caldas C, Kristensen VN, Brazma A, Børresen-Dale AL, Hovig E, Helland Å (2016) Subtype-specific micro-RNA expression signatures in breast cancer progression. Int J Cancer 139(5):1117–1128. https://doi.org/10.1002/ijc.30142
    Rask L, Balslev E, Søkilde R, Høgdall E, Flyger H, Eriksen J, Litman T (2014) Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status. Cell Oncol (Dordr) 37(3):215–227. https://doi.org/10.1007/s13402-014-0176-6
    Krishnan K, Steptoe AL, Martin HC, Pattabiraman DR, Nones K, Waddell N, Mariasegaram M, Simpson PT, Lakhani SR, Vlassov A, Grimmond SM, Cloonan N (2013) miR-139-5p is a regulator of metastatic pathways in breast cancer. RNA 19(12):1767–1780. https://doi.org/10.1261/rna.042143.113
    Qiu G, Lin Y, Zhang H, Wu D (2015) miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2. Biochem Biophys Res Commun 463(3):315–321. https://doi.org/10.1016/j.bbrc.2015.05.062
    Yue S, Wang L, Zhang H, Min Y, Lou Y, Sun H, Jiang Y, Zhang W, Liang A, Guo Y, Chen P, Lv G, Zong Q, Li Y (2015) miR-139-5p suppresses cancer cell migration and invasion through targeting ZEB1 and ZEB2 in GBM. Tumour Biol 36(9):6741–6749. https://doi.org/10.1007/s13277-015-3372-8
    Li Q, Liang X, Wang Y, Meng X, Xu Y, Cai S, Wang Z, Liu J, Cai G (2016) miR-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2. Sci Rep 6:27157. doi: https://doi.org/10.1038/srep27157
    Watanabe K, Amano Y, Ishikawa R, Sunohara M, Kage H, Ichinose J, Sano A, Nakajima J, Fukayama M, Yatomi Y, Nagase T, Ohishi N, Takai D (2015) Histone methylation-mediated silencing of miR-139 enhances invasion of non-small-cell lung cancer. Cancer Med 4(10):1573–1582. https://doi.org/10.1002/cam4.505
    Liu Y, Uzair-Ur-Rehman GY, Liang H, Cheng R, Yang F, Hong Y, Zhao C, Liu M, Yu M, Zhou X, Yin K, Chen J, Zhang J, Zhang CY, Zhi F, Chen X (2016) miR-181b functions as an oncomiR in colorectal cancer by targeting PDCD4. Protein Cell 7(10):722–734. https://doi.org/10.1007/s13238-016-0313-2
    Huang S, Wang J, Li J, Luo Q, Zhao M, Zheng L, Dong X, Chen C, Che Y, Liu P, Qi J, Huang C (2016) Serum microRNA expression profile as a diagnostic panel for gastric cancer. Jpn J Clin Oncol 46(9):811–818. https://doi.org/10.1093/jjco/hyw085
    Zheng Y, Lv X, Wang X, Wang B, Shao X, Huang Y, Shi L, Chen Z, Huang J, Huang P (2016) MiR-181b promotes chemoresistance in breast cancer by regulating Bim expression. Oncol Rep 35(2):683–690. https://doi.org/10.3892/or.2015.4417
    Sochor M, Basova P, Pesta M, Dusilkova N, Bartos J, Burda P, Pospisil V, Stopka T (2014) Oncogenic microRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum. BMC Cancer 14:448. https://doi.org/10.1186/1471-2407-14-448
    Liu J, Shi W, Wu C, Ju J, Jiang J (2014) miR-181b as a key regulator of the oncogenic process and its clinical implications in cancer (Review). Biomed Rep 2(1):7–11. https://doi.org/10.3892/br.2013.199
    Cai B, An Y, Lv N, Chen J, Tu M, Sun J, Wu P, Wei J, Jiang K, Miao Y (2013) miRNA-181b increases the sensitivity of pancreatic ductal adenocarcinoma cells to gemcitabine in vitro and in nude mice by targeting BCL-2. Oncol Rep 29(5):1769–1776. https://doi.org/10.3892/or.2013.2297
    Wang J, Sai K, Chen FR, Chen ZP (2013) miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1. Cancer Chemother Pharmacol 72(1):147–158. https://doi.org/10.1007/s00280-013-2180-3
    Wang X, Chen X, Meng Q, Jing H, Lu H, Yang Y, Cai L, Zhao Y (2015) MiR-181b regulates cisplatin chemosensitivity and metastasis by targeting TGFβR1/Smad signaling pathway in NSCLC. Sci Rep 5:17618. https://doi.org/10.1038/srep17618
    Shao JL, Li ZZ, Wang L, Jiao GL, Zhou ZG, Sun GD (2016) microRNA-181b promotes migration and invasion of osteosarcoma cells by targeting N-myc downstream regulated gene 2. Nan Fang Yi Ke Da Xue Xue Bao 36(3):321–326
    Nakajima G, Hayashi K, Xi Y, Kudo K, Uchida K, Takasaki K, Yamamoto M, Ju J (2006) Non-coding MicroRNAs hsa-let-7g and hsa-miR-181b are Associated with Chemoresponse to S-1 in Colon Cancer. Cancer Genomics Proteomics 3(5):317–324
    Hu L, Ai J, Long H, Liu W, Wang X, Zuo Y, Li Y, Wu Q, Deng Y (2016) Integrative microRNA and gene profiling data analysis reveals novel biomarkers and mechanisms for lung cancer. Oncotarget 7 (8):8441-8454. doi: 10.18632/oncotarget.7264
    Li X, Li D, Zhuang Y, Shi Q, Wei W, Ju X (2013) Overexpression of miR-708 and its targets in the childhood common precursor B-cell ALL. Pediatr Blood Cancer 60(12):2060–2067. https://doi.org/10.1002/pbc.24583
    Li G, Yang F, Xu H, Yue Z, Fang X, Liu J (2015) MicroRNA-708 is downregulated in hepatocellular carcinoma and suppresses tumor invasion and migration. Biomed Pharmacother 73:154–159. https://doi.org/10.1016/j.biopha.2015.05.010
    Lei SL, Zhao H, Yao HL, Chen Y, Lei ZD, Liu KJ, Yang Q (2014) Regulatory roles of microRNA-708 and microRNA-31 in proliferation, apoptosis and invasion of colorectal cancer cells. Oncol Lett 8(4):1768–1774. https://doi.org/10.3892/ol.2014.2328
    Lin KT, Yeh YM, Chuang CM, Yang SY, Chang JW, Sun SP, Wang YS, Chao KC, Wang LH (2015) Glucocorticoids mediate induction of microRNA-708 to suppress ovarian cancer metastasis through targeting Rap1B. Nat Commun 6:5917. https://doi.org/10.1038/ncomms6917
    Ryu S, McDonnell K, Choi H, Gao D, Hahn M, Joshi N, Park SM, Catena R, Do Y, Brazin J, Vahdat LT, Silver RB, Mittal V (2013) Suppression of miRNA-708 by polycomb group promotes metastases by calcium-induced cell migration. Cancer Cell 23(1):63–76. https://doi.org/10.1016/j.ccr.2012.11.019
    Saini S, Yamamura S, Majid S, Shahryari V, Hirata H, Tanaka Y, Dahiya R (2011) MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells. Cancer Res 71(19):6208–6219. https://doi.org/10.1158/0008-5472.CAN-11-0073
    Yan W, Li R, Liu Y, Yang P, Wang Z, Zhang C, Bao Z, Zhang W, You Y, Jiang T (2014) MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis. Oncotarget 5(24):12908–12915. 10.18632/oncotarget.2679
    Xue H, Guo X, Han X, Yan S, Zhang J, Xu S, Li T, Zhang P, Gao X, Liu Q, Li G (2016) MicroRNA-584-3p, a novel tumor suppressor and prognostic marker, reduces the migration and invasion of human glioma cells by targeting hypoxia-induced ROCK1. Oncotarget 7(4):4785–4805. 10.18632/oncotarget.6735
    Wang XP, Deng XL, Li LY (2014) MicroRNA-584 functions as a tumor suppressor and targets PTTG1IP in glioma. Int J Clin Exp Pathol 7(12):8573–8582
    Guled M, Lahti L, Lindholm PM, Salmenkivi K, Bagwan I, Nicholson AG, Knuutila S (2009) CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis. Genes Chromosomes Cancer 48(7):615–623. https://doi.org/10.1002/gcc.20669
    Gaedcke J, Grade M, Camps J, Søkilde R, Kaczkowski B, Schetter AJ, Difilippantonio MJ, Harris CC, Ghadimi BM, Møller S, Beissbarth T, Ried T, Litman T (2012) The rectal cancer microRNAome--microRNA expression in rectal cancer and matched normal mucosa. Clin Cancer Res 18(18):4919–4930. https://doi.org/10.1158/1078-0432.CCR-12-0016
    Ueno K, Hirata H, Shahryari V, Chen Y, Zaman MS, Singh K, Tabatabai ZL, Hinoda Y, Dahiya R (2011) Tumour suppressor microRNA-584 directly targets oncogene Rock-1 and decreases invasion ability in human clear cell renal cell carcinoma. Br J Cancer 104(2):308–315. https://doi.org/10.1038/sj.bjc.6606028
    Xiang J, Wu Y, Li DS, Wang ZY, Shen Q, Sun TQ, Guan Q, Wang YJ (2015) miR-584 Suppresses Invasion and Cell Migration of Thyroid Carcinoma by Regulating the Target Oncogene ROCK1. Oncol Res Treat 38(9):436–440. https://doi.org/10.1159/000438967